EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

YAP/TAZ are crucial regulators of macrophage-mediated pulmonary inflammation and fibrosis after bleomycin-induced injury

Masum M Mia, Siti Aishah Binte Abdul Ghani, Dasan Mary Cibi, Hanumakumar Bogireddi, Uthayanan Nilanthi iD, Ashwatthaman Selvan, Wai Shiu Fred Wong, Manvendra K Singh iD

European Respiratory Journal · 2025-06 · 65 (6) · 2301544

DOI: 10.1183/13993003.01544-2023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Respiratory Journal, online erschienen am 28.03.2025. Verfasst von Masum M Mia und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School Singapore, Singapore, Singapore. Hauptthemen laut MEDLINE: Pulmonary Fibrosis, Adaptor Proteins, Signal Transducing, Macrophages, Alveolar, Transcription Factors. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary fibrosis is the most prevalent and severe form of end-stage interstitial lung disease. Macrophages are crucial players in inflammation-induced pulmonary fibrosis, but the mechanisms driving macrophage polarisation and their specific roles in pulmonary fibrosis pathogenesis remain poorly understood. Here, we demonstrate that both YAP and TAZ are activated in lung macrophages from patients with pulmonary fibrosis as well as in mice with bleomycin-induced pulmonary fibrosis. Myeloid-specific Yap/Taz deletion resulted in reduced recruitment of monocyte-derived alveolar macrophages (Mo-AMs), impaired inflammatory responses, decreased pulmonary fibrosis and enhanced alveolar epithelial cell regeneration following bleomycin treatment. Conversely, the expression of a constitutively active YAP mutant (YAP 5SA ) exacerbated bleomycin-induced pulmonary fibrosis by increasing Mo-AM recruitment, elevating expression of pro-inflammatory and pro-fibrotic markers, and impairing alveolar epithelial cell regeneration. We demonstrate that YAP/TAZ-CCL2 (C-C motif chemokine ligand 2) signalling plays a crucial role in bleomycin-induced pulmonary fibrosis, as blocking CCL2 with a neutralising antibody effectively abrogated the YAP 5SA -induced recruitment of Mo-AMs, inflammatory and fibrotic responses. Additionally, we reveal that the YAP/TAZ-MBD2-TGFβ1-pSMAD2 signalling axis is crucial not only for pro-fibrotic macrophage polarisation, but also for their cross-talk with lung fibroblasts, driving the fibroblast-to-myofibroblast transition. Collectively, these findings suggest that targeting aberrant YAP/TAZ activity to modulate inflammatory and fibrotic response could be a promising strategy for the prevention and treatment of pulmonary fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary FibrosisAdaptor Proteins, Signal TransducingMacrophages, AlveolarTranscription FactorsPneumoniaBleomycinAnimalsMiceYAP-Signaling ProteinsHumansSignal TransductionMice, Inbred C57BLCell Cycle ProteinsTrans-ActivatorsMaleChemokine CCL2Alveolar Epithelial CellsTransforming Growth Factor beta1Transcriptional Coactivator with PDZ-Binding Motif ProteinsMacrophagesAcyltransferasesMice, Knockout

Substanzen

BleomycinYAP-Signaling ProteinsAdaptor Proteins, Signal TransducingYap1 protein, mouseTranscription FactorsWwtr1 protein, mouseCell Cycle ProteinsTrans-ActivatorsChemokine CCL2YAP1 protein, human

Autor:innen und Institutionen

  • Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School Singapore, Singapore, Singapore.
  • Department of Pharmacology, Yong Loo Lin School of Medicine, National University Health System, Singapore, Singapore.
  • Singapore-HUJ Alliance for Research and Enterprise, Molecular Mechanisms of Inflammatory Disease Program, National University of Singapore, Singapore, Singapore.
  • Drug Discovery and Optimization Platform, Yong Loo Lin School of Medicine, Singapore, Singapore.
  • Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School Singapore, Singapore, Singapore manvendra.singh@duke-nus.edu.sg.
  • National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore, Singapore.

ORCID-Profile: Uthayanan Nilanthi, Manvendra K Singh

Förderung

  • National Medical Research Council

Zitieren

APA

Mia, M. M., Ghani, S. A. B. A., Cibi, D. M., Bogireddi, H., Nilanthi, U., Selvan, A., Wong, W. S. F., & Singh, M. K. (2025). YAP/TAZ are crucial regulators of macrophage-mediated pulmonary inflammation and fibrosis after bleomycin-induced injury. European Respiratory Journal, 65(6), 2301544. https://doi.org/10.1183/13993003.01544-2023

Vancouver

Mia MM, Ghani SABA, Cibi DM, Bogireddi H, Nilanthi U, Selvan A, et al. YAP/TAZ are crucial regulators of macrophage-mediated pulmonary inflammation and fibrosis after bleomycin-induced injury. European Respiratory Journal. 2025;65(6):2301544. doi:10.1183/13993003.01544-2023

BibTeX
@article{Mia2025,
  author = {Mia, Masum M and Ghani, Siti Aishah Binte Abdul and Cibi, Dasan Mary and Bogireddi, Hanumakumar and Nilanthi, Uthayanan and Selvan, Ashwatthaman and Wong, Wai Shiu Fred and Singh, Manvendra K},
  title = {YAP/TAZ are crucial regulators of macrophage-mediated pulmonary inflammation and fibrosis after bleomycin-induced injury},
  journal = {European Respiratory Journal},
  year = {2025},
  volume = {65},
  number = {6},
  pages = {2301544},
  doi = {10.1183/13993003.01544-2023}
}
Kostenlos starten →